Expression of genes of apoptotic pathways during the development
Transkrypt
Expression of genes of apoptotic pathways during the development
Animal Science Papers and Reports vol. 24 (2006) no. 1, 47-56 Institute of Genetics and Animal Breeding, Jastrzębiec, Poland Expression of genes of apoptotic pathways during the development of mammary gland in mice* Tadeusz Malewski1, Małgorzata Krzyżowska2, Stanisław Kamiński3, Lech Zwierzchowski1, Zofia Szymańczak1 1 Department of Molecular Biology, Polish Academy of Sciences Institute of Genetics and Animal Breeding, Jastrzębiec, 05-552 Wólka Kosowska, Poland 2 Department of Preclinical Sciences, Faculty of Veterinary Medicine, Warsaw Agricultural University, Ciszewskiego 8, 02-786 Warsaw, Poland 3 Department of Animal Genetics, University of Warmia and Mazury in Olsztyn, Oczapowskiego 5, 10-719 Olsztyn, Poland (Received December 19, 2005; accepted February 10, 2006) The Panorama Mouse Apoptosis Gene Array containing 243 genes was used in profiling the gene expression of mammary gland in mice. In all reports dealing with mammary gland development that were considered in this study, expression of apoptosis-related genes was identified on both pathways, i.e. on death receptor and mitochondrial-mediated pathway. The results obtained suggest that tumour necrosis factor (TNF) receptor pathway prevails during pregnancy. Transition from pregnancy to lactation alters the expression rate of many apoptosis-related genes, functions of which in apoptosis are not yet defined precisely. KEY WORDS: apoptosis / gene expression / macroarray /mammary gland The removal of superfluous, defective, damaged, or dangerous cells is critical for normal development and tissue homeostasis in multicellular organisms. The molecular * Supported by the Ministry of Education and Science grant No 3 P06D 017 23 47 T. Malewski et al. control of the genetically programmed cell death process has been evolutionarily conserved in metazoans [Kerr et al. 1980, Majno and Joris 1995]. Apoptosis is driven by a family of aspartate-specific cysteine proteases, known as caspases, which cleave many cellular proteins and proteolytically activate enzymes that contribute to cell destruction [Kerr et al. 1980, Majno and Joris 1995, Robertson et al. 2000]. In mammals there are two principal signalling pathways of apoptosis that converge at the level of caspase activation [Rathmell and Thompson 1999]. One is a direct pathway from death receptor to caspase cascade activation and cell death. Death receptor ligation triggers recruitment of the precursor of caspase 8 to a death-inducing complex through the Fas-associated protein with death domain (FADD), which leads to caspase 8 activation. The other pathway is triggered by stimuli such as drugs, radiation, infectious agents and reactive oxygen and is initiated in mitochondria. After cytochrome c is released into the cytosol from the mitochondria, it binds to Apaf1 and ATP, which then activate caspase 9 [Kroemer and Reed 2000]. Activation of initiator caspase 8 and caspase 9 results in activation of effector caspases, such as caspase 3. Recently, endoplasmic reticulum has also been shown to execute apoptosis [Kroemer and Reed 2000] Apoptosis plays an important role in sculpturing the overall shape and organization of organs during development and tissue remodelling [Bissell et al. 2003]. The morphogenesis of organs typically involves the coordination of several cellular processes, including migration, proliferation, apoptosis and changes in cell shape or polarity [Bissell et al. 2003]. The morphogenesis of milk ducts in the development of the mammary gland is dependent on the selective death of epithelial cells to form mammary acini, in which a hollow tube lined with polarized mammary epithelial cells is formed. Following lactation, in the mammary gland involution process develops, culminating in return of the organ to a pre-pregnancy state. In involution stage I the appearance of apoptotic mammary epithelial cells takes place in the alveoli. In stage II destruction of the lobular-alveolar architecture of the gland and apoptosis of mammary epithelial cells follow, as cells loose connections with extracellular matrix and basement membrane [Lund et al. 1996]. Gene expression profiling of mouse mammary gland during transition from pregnancy to lactation showed significant changes in expression of numerous apoptosis-related genes [Malewski et al. 2005, Master et al. 2002]. The aim of the current study was to profile the expression of apoptosis-related factors, caspases and mitochondrial-associated proteins involved in signalling pathways during pregnancy, lactation and subsequent involution of mammary gland in mice. Material and methods Animals and tissues Mammary gland samples of MIIZ mice at four different physiological stages were used (six samplings), obtained from following groups of animals: 7 weeks-old virgin 48 Apoptotic pathway genes expression during mammary gland development mice (V), mice on day 6 and day16 of pregnancy (P6 and P16, respectively), mice on day 1 of lactation (L), and mice on post-weaning day 3 and day 8 (mammary gland involution, In3 and In8, respectively). Tisue samples were excised immediately after animal cervical dislocation, cleared from most adjacent muscles, fat and connective tissues, frozen at -25°C and stored at -75°C until use. RNA extraction Total RNA was extracted with TRI Reagent (SIGMA-ALDRICH ) according to the manufacturer’s protocol. To quantify the amount of total RNA extracted, the absorbance at 260 nm was measured with DU-68 Spectrophotometer (BECKMAN). RNA integrity was electrophoretically verified in agarose gels stained with 1.5% ethidium bromide. cDNA macroarray For cDNA synthesis equal volumes of RNA were extracted from five mice at each of four investigated stages (six samplings), and pooled. To confirm the validity of the assay, cDNA synthesis was performed in duplicate. The cDNA labelling reactions were performed in two steps according to the manufacturer’s protocol. Details of labelled cDNA synthesis and hybridization were those described by Malewski et al. [2005]. Briefly, Nylon array (Panorama Mouse Apoptosis Gene Array, SIGMAGenosys, The Woodlands, TX) were hybridized with labelled probes at 65°C overnight. After hybridization, the nylon membranes were washed with 0.5×SSPE + 1% sodium dodecyl sulphate (SDS) and 0.1×SSPE + 1% SDS, and then exposed to Phosphorscreen (KODAK, Japan) for 24 h. The screens were scanned by BioRad FX Scanner. Results from three independent hybridizations were obtained for each probe. Images were analysed by Quantity One (BioRad) software. Each image was overlaid with grids so that signal intensities of individual spots could be assessed. Local background for each membrane was calculated on the basis of 10 positions with no DNA-spotted area. Expression levels of individual genes are presented in arbitrary units after subtracting background. Intensity-based global normalization was then performed. Results and discussion Macroarrays provide a powerful tool for analysing complex biological systems. In this study we simultaneously analysed 243 transcripts to determine basic expression pattern of genes associated with apoptosis in adult mouse mammary gland. Examples of some macroarray analyses are shown in Figure 1. Probes present in the Panorama Mouse Apoptosis Gene Array cover eight ontologic categories as defined by the Gene Ontology Consortium (http://www.geneontology.org) - Khatri et al. [2002]. Apoptosis-related factors are represented by 66 probes belonging to those categories. Results of expression profiling of apoptosis pathways genes during the development 49 T. Malewski et al. Fig. 1. Examples of microarray analyses. A – electrophoretic image of RNA isolated from mammary glands of mice: V – virgin mice seven-weeks old; P6 and P16 – mice on day 6 and day 16 of pregnancy; L – mice on day 1 of lactation; I3 and I8 – mice on day 3 and day 8 of mammary gland involution. B – DNA array hybridization from lactation day 1 (L); C – DNA hybridization from inhibition day 3 (I3). Hybridizations were performed using radioactive 32P-labelled probes prepared from lactating and involuting mammary glands of five animals each. Indicated are changes in expression of selected genes during transition from lactation to involution. 50 Akt1 Bag1 Bak1 Bcl2l1 Bcl2l2 Birc2 Birc3 Birc5 Casp1 Casp2 Cav2 Cd180 Cd47 Cidea Cldn3 Clu Ctsd Cycs Dap Dffa Dnase2 Dnclc1 Dpf2 Fadd Gpx1 Gsn Gzmb Hnrpa1 Lgals Mcl1 Gene symbol NM_009652 NM_009736 NM_007523 NM_009743 NM_007537 NM_007465 NM_007464 NM_009689 NM_009807 NM_007610 AF141322 NM_008533 NM_010581 NM_007702 NM_009902 L08235 NM_009983 NM_007808 AI196645 NM_010044 NM_010062 NM_019682 NM_011262 NM_010175 NM_008160 NM_010354 NM_013542 NM_010447 X16834 NM_008562 Gene Bank acc. No. Thymoma viral proto-oncogene 1 Bcl2-associated athanogene 1 Bcl2-antagonist/killer 1 Bcl2-like 1 Bcl2-like 2 Baculoviral IAP repeat-containing 2 Baculoviral IAP repeat-containing 3 Baculoviral IAP repeat-containing 5 Caspase 1 Caspase 2 Caveolin2 CD 180 antigen CD47 antigen DNA fragmentation factor, alpha subunit-like effector A Claudin 3 Clustrin Cathepsin D Cytochrome c, somatic Death-associated protein DNA fragmentation factor, alpha subunit Deoxyribonuclease II alpha Dynein, cytoplasmic, light chain 1 D4, zinc and double PHD fingers family 2 Fas (TNFRSF6)-associated via death domain Glutathione peroxidase 1 Gelsolin Granzyme B Heterogeneous nuclear ribonucleoprotein A1 Lectin, galactose binding, soluble 3 Myeloid cell leukemia sequence 1 Gene name Table 1. Expression profiling of genes in the murine mammary gland of mice 3.39 R N I 16.78 N N N I N 0.32 N I N I 0.19 0.19 0.51 3.64 1.34 N R I N 0.25 0.12 I 0.10 N 0.79 1.21 I N 0.63 0.81 N N N N N 1.12 N 1.41 N 1.57 2.74 1.72 0.79 0.89 1.40 N I 0.80 N 1.11 0.82 R 2.74 N 0.69 0.78 R N 1.25 0.90 N N I N I R N 0.58 I 1.05 0.34 0.49 0.68 1.14 1.13 N R 1.08 N R R N R N 1.55 0.97 I I 0.89 0.85 I I R I 1.01 N I 1.39 0.16 0.75 2.28 2.72 0.82 0.78 1.77 I I 1.34 I I I I I I 0.82 1.09 6.46 R R 0.19 R R N R R I R 1.71 6.29 R 1.18 4.43 4.28 0.40 R R R 0.98 R 1.39 24.45 R 4.00 R 1.26 Gene mRNA amount at different stages of mammary gland development P6/V P16/P6 L/P16 In3/L In8/In3 Apoptotic pathway genes expression during mammary gland development 51 52 NM_008594 NM_008771 NM_013614 NM_008798 NM_011107 NM_011113 NM_008898 NM_011163 NM_008960 AB041997 AF117759 AB017337 AW106709 NM_009383 NM_011609 NM_011610 NM_009399 NM_001033161 NM_011660 Mfge8 Mt2 Odc1 Pdcd1 Pla2g1b Plau Por Prkr Pten Ptges Sfrp5 Srebf1 Srebf2 Tial1 Tnfr1a Tnfrsf1b Tnfrsf11a Tradd Txn Milk fat globule-EGF factor 8 protein Metallothionein 2 Ornithine decarboxylase, structural 1 Programmed cell death 1 Phospholipase A2, group IB, pancreas Plasminogen activator, urokinase P450 (cytochrome) oxidoreductase Double standed RNA-dependent protein kinase Phosphatase and tensin homolog Prostaglandin E synthase Secreted frizzled-related protein 5 Sterol regulatory element-binding protein-1 Sterol regulatory element binding factor 2 Cytotoxic granule-associated RNA-binding protein-like 1 Tumor necrosis factor receptor superfamily, member 1a Tumor necrosis factor receptor superfamily, member 1b Tumor necrosis factor receptor superfamily, member 11a TNFRSF1A-associated via death domain Thioredoxin Gene name *Gene mRNA abundance at different stages of mammary gland development. R - gene repression. I - gene induction. N - gene expression not found. Gene Bank acc. No. Gene symbol Table 1 continued. I I I N N I N N 0.23 N I N 0.36 N I N N N 0.21 0.99 R 3.13 N I R N I 1.29 I 0.81 I 2.70 I R N I I 1.28 2.95 I 0.62 I 1.23 N N R R R 1.19 R 0.61 R N N 1.05 R 0.21 0.81 1.18 0.28 0.46 R I N N I N 1.31 N 1.05 I I I 1.89 N 4.66 1.08 1.64 R R N R I N 5.86 N R I 1.94 3.50 R R R N 1.60 Gene mRNA amount at different stages of mammary gland development P6/V P16/P6 L/P16 In3/L In8/In3 T. Malewski et al. Apoptotic pathway genes expression during mammary gland development of mouse mammary gland obtained in the present study are shown in Table 1. Genes involved in death receptor pathways of apoptosis During early pregnancy (P6) up-regulation of caspase 2 gene was observed, followed by up-regulation of gene Tnfr1, what indicates activation of TNFR1dependent pathway of apoptosis. On day 16 of pregnancy (P16) and during the involution (In3 and In8), both caspase 2 and Tnrf1 expression were down-regulated. The up-regulation of gene Tradd with no simultaneous up-regulation of gene Fadd, the latter encoding death-inducing protein adaptor, indicates that during pregnancy both Tnfr1 and Tnfr2 are involved in cell survival and proliferation rather, than in apoptosis. Apart from TNFR1, expression of other members of TNF receptor superfamily was observed in mammary gland [Hsu et al. 1996]. Besides their role in apoptosis, most of them have other functions, such as participation in proliferation, differentiation, immune regulation, and gene expression. Receptors with pleiotropic functions include TNF-R1, TNF-R2, NGF-R and RANK. These receptors are structurally similar membrane proteins of type I. In its extracellular domain each receptor possesses from 2 to 6 imperfect repeats of about 40 amino acids, each with approximately six Cys residues. Their cytoplasmic domains generally lack considerable sequence similarity [Hsu et al. 1995, 1996, Dempsey et al. 2003]. The recently identified TNF superfamily member – TRANCE (RANKL/TNFSF11) – has been shown to play essential role in the developmental processes leading to both lymph node formation, and function of mammary glands during pregnancy and lactation [Walsh and Choi 2003]. TRANCE interacts with TRANCE-R (RANK/TNFRSF11A) receptors. It has been shown by Fata et al. [2000] that TRANCE-R is constitutively expressed throughout the mammary gland and TRANCE-deficient mice fail to undergo mammary gland development during pregnancy, resulting in dramatic decrease in the amount of the β-casein yielded during lactation. Indeed, Table 1 demonstrates that expression of gene Tnfrsf11a was up-regulated on day P16 and down-regulated during involution days In3 and In8. Death receptor-mediated apoptosis pathway may also be regulated by kinases. Phosphoinositide 3-kinase (PI3K) possesses a dual-specificity with lipid and protein activity. One of its targets is the protein kinase B (PKB or AKT). The PI3-K/PKB pathway has been shown to deliver an anti-apoptotic signal, which is negatively regulated by the lipid and protein phosphatase Pten [Datta et al. 1999, li et al. 1997]. In the current study, expression of Akt/Pkb gene during pregnancy was upregulated, to become down-regulated during involution, which was accompanied by Pten up-regulation. Interestingly, down-regulation of apoptosis-inhibiting genes Birc2 (formerly named cIAP-2) and Birc3 (formerly named cIAP-1) was observed by Deveraux and Reed [1999] on day In8. Birc2 and Birc3 proteins bind to TNF-α receptor–associated factor 1 and 2 (Traf1 and Traf2) and thus can be recruited to 53 T. Malewski et al. the activated TNFR complex. X-linked IAP, Birc2, and Birc3 were shown to interact with and inhibit downstream caspases 3 and 7, thereby inhibiting apoptosis initiated either by receptor-mediated or by cytochrome c-dependent mechanisms [Deveraux and Reed 1999, Shiozaki 2004]. Genes involved in mitochondrial pathways of apoptosis Second pathway of apoptosis induction involves release of cytochrome c from mitochondrial intermembranous space into the cytoplasm. Cytochrome c, together with protein Apaf1, interacts with caspase 9. Interaction between Apaf1 and caspase 9 leads to activation of the latter [Rathmell and Thompson 1999, Kim 2005, Kluck et al. 1997]. Mitochondrial pathway of apoptosis induction is regulated by the family of proteins named Bcl-2. In mammals, this family consists of both pro- and antiapoptotic proteins, which show both sequential and structural similarity in the BH (Bcl2 homology) domains [Rathmell and Thompson 1999]. The anti-apoptotic factors include Bcl-2, Bcl2l2 (formerly named Bcl-w), Bcl2l1 (formerly named Bcl-xL), Bcl2l10 (formerly named Boo/Diva/Bcl-B), and Mcl1 [Rathmell and Thompson 1999, Boise et al. 1993, Gibson et al. 1996]. These proteins all share three or four BH domains, and they occur in the cytoplasmic site of intracellular membranes, such as the outer mitochondrial membrane, the endoplasmic reticulum, and the nuclear envelope. A subgroup of pro-apoptotic Bcl-2 family members, including Bax, Bak, Bcl2l1 (former name Bcl-xs) and Bcl-GL, have two or three BH domains and are structurally very similar to their prosurvival relatives [Rathmell and Thompson 1999, Kluck et al. 1997, Boise et al. 1993]. The latter proteins act as sensors for apoptotic stimuli and initiate the apoptotic cascade that can be antagonized by Bcl-2. In this study, regulation of expression of both pro-apoptotic and anti-apoptotic mitochondria-related factors was shown (Tab. 1) during pregnancy, lactation and involution. In early pregnancy (P6) observed was induction of anti-apoptotic genes Bcl2l1, Bcl2l2 and Mcl1 accompanied by up-regulation of cytochrome c gene encoding mitochondrial pathway key protein. Later in pregnancy (P16) expressions of Bcl2l1, Bcl2l2, Mcl1 and cytochrome c were reduced, then remained unchanged during lactation, and were followed by reduction of expression during the whole involution phase tested (In3 and In8) Additionally, on day In8, up-regulation of cytochrome c was observed, indicating possible induction of apoptosis. Bcl-2 protein is the target of Bag1. Bag1 prevents the release of pro-apoptotic factors such as cytochrome c from mitochondria, important for activation of caspases in response to many apoptotic inducers [Takayama and Reed 2001, Townsend et el. 2003]. Expression of Bag1 was repressed on day P6 and induced by day P16, then repressed during lactation, induced again on day In3 and increased on day In8. Expression of Bag1 during pregnancy was inversely regulated in comparison to expression of anti-apoptotic genes Bcl2l1, Bcl2l2 and Mcl1 and co-regulated with cytochrome c indicating its involvement in apoptosis suppression. 54 Apoptotic pathway genes expression during mammary gland development Macroarray analysis of mice mammary gland gives outlook of activity of genes related to apoptosis at different stages of mammary gland development. This allows choosing the correct set of genes for future research of apoptosis and tissue remodelling during development. The results presented here suggest that the TNF receptor pathway prevailes during pregnancy. Transition from pregnancy to lactation changes the intensity of expression of many apoptosis-related genes, function(s) of which in apoptotic pathways is (are) not precisely defined. REFERENCES 1. BISSELL M.J., Rizki A., Mian I.S., 2003 – Tissue architecture: the ultimate regulator of breast epithelial function. Current Opinion in Cell Biology 15, 753‑762. 2. Boise L.H., Gonzalez-Garcia M., Postema C.E., Ding L., Lindsten T., Turka L.A., Mao X., Nunez G., Thompson C.B., 1993 – Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74, 597- 608. 3. Datta S.R., Brunet A., Greenberg M.E., 1999 – Cellular survival: a play in three acts. Genes and Development 13, 2905-2927. 4. Dempsey P.W., Doyle S.E., He J.Q., Cheng G., 2003 – The signalling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Review 14, 193-209. 5. Deveraux Q.L., Reed J.C., 1999 – IAP family proteins – supressors of apoptosis. Genes and Development 13, 239-252. 6. Fata J.E., Kong Y.Y., Li J., Sasaki T., Irie-Sasaki J., Moorehead R.A., Elliott R., Scully S., Voura E.B., Lacey D.L., Boyle W.J., Khokha R., Penninger J.M., 2000 – The osteoclast differentiation factor osteoprotegrin-ligand is essential for mammary gland development Cell 103, 41-50. 7. Gibson L., Holmgreen S.P., Huang D.C., Bernard O., Copeland N.G., Jenkins N.A., Sutherland G.R., Baker E., Adams J.M., Cory S., 1996 – Bcl-w, a novel member of the bcl-2 family, promotes cell survival. Oncogene 13, 665-675. 8. Hsu H., Shu H.B., Pan M.G., Goeddel D.V., 1996 – TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84, 299-308. 9. Hsu H., Xiong J., Goeddel D.V., 1995 – The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 81, 495-504. 10. Kerr J.F.R., Wyllie A.H, Currie A.R., 1980 – Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. British Journal of Cancer 26, 239-257. 11. KHATRI P., DRAGHICI S., OSTERMEIER G.C., KRAWETZ S.A., 2002 – Profiling gene expression using onto-express. Genomics 79, 266-270. 12. KiM R., 2005 – Unknotting the roles of Bcl-2 and Bcl-xL in cell death. Biochemistry and Biophysics Research Communications 333, 336-343. 13. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D., 1997 – The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275, 1132–1136. 14. KROEMER G., REED J.C., 2000 – Mitochondrial control of cell death. Nature Medicine 6, 513519. 15. LI J., YEN C., LIAW D., PODSYPANIA K., BOSE S., WANG S.I., PUC J., MILIARENSIS C., RODGERS L., MCCOMBIE R., BITNER S.H., GIOVANELLA B.C., ITTMANN M., TYCKO B., HIBSHOOSH, WIGLER M.H., PARSONS R., 1997 – PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science 275, 1943-1947. 16. Lund L.R., Romer J., Thomasset N., Solberg H., Pyke C., Bissell M.J., Dano 55 T. Malewski et al. 17. 18. 19. 20. 21. 22. 23. 24. 25. K., Werb Z., 1996 – Two distinct phases of apoptosis in mammary gland involution: proteinaseindependent and -dependent pathways. Development 122, 181-193. Majno G., Joris I., 1995 – Apoptosis, oncosis, and necrosis: an overview of cell death. American Journal of Pathology 146, 3-15. Malewski T., Kamiński S., zwierzchowski l., 2005 – gene expression profiling of mouse mammary gland: transition from pregnancy to lactation. Animal Science Papers and Reports 23, 159-169. MASTER S.R., HARTMAN J.L., D’CRUZ C.M., MOODY S.E., KEIPER E.A., HA S.J., COX J.D., BELKA S.K., CHODOSH L.A., 2002 - Functional microarray analysis of mammary organogenesis reveals a developmental role in adapive thermogenesis. Molecular Endocrinology 16, 1185-1203. Rathmell J.C., Thompson C.B., 1999 – The central effectors of cell death in the immune system. Annual Review in Immunology 17, 781-828. Robertson J.D., Orrenius S., Zhivotovsky B., 2000 – Review: nuclear events in apoptosis. Journal of Structural Biology 129, 346-358. Shiozaki E.N., 2004 – Caspases, IAPs and Smac/DIABLO: mechanisms from structural biology. Trends in Biochemical Science 29, 486-494. Takayama S., Reed J.C., 2001 – Molecular chaperone targeting and regulation by BAG family proteins. Nature Cell Biology 3, E237-241. Townsend P.A., Cutress R.I., Sharp A., Brimmell M., Packam G., 2003 – Bag-1: a multifunctional regulator of cell growth and survival. Biochemica and Biophysica Acta 1603, 83-98. Walsh M.C., Choi Y., 2003 – Biology of the TRANCE axis. Cytokine Growth Factor Review 14, 252-263. Tadeusz Malewski, Małgorzata Krzyżowska, Stanisław Kamiński, Lech Zwierzchowski, Zofia Szymańczak Profilowanie ekspresji genów szlaków apoptozy w gruczole mlekowym myszy Streszczenie Dokonano profilowania ekspresji 243 genów w gruczole mlekowym myszy stosując makromacierz Panorama Mouse Apoptosis Gene Array. Ekspresję genów szlaków receptorowego i mitochondrialnego stwierdzono w gruczole mlekowym myszy we wszystkich czterech badanych stadiach jego rozwoju – u siedmiotygodniowych myszy dziewiczych, myszy ciężarnych (w 6 i 16 dniu ciąży), w pierwszym dniu laktacji i po odsadzeniu młodych (3 i 8 dzień inwolucji). Uzyskane wyniki wskazują, że szlak receptora TNF jest głównym szlakiem apoptozy podczas ciąży. Przejściu od ciąży do laktacji towarzyszy zmiana ekspresji wielu genów biorących udział w apoptozie, których funkcja nie została jeszcze dokładnie określona. 56